The neuroprotective effect of MT exhibited via variety of mechanisms such as reducing phosphorylation of Tau proteins through inhibition of the ubiquitin-dependent degradation of PP2A resulted in an elevation of PP2A level and dephosphorylation of Tau in AD [52]. Here, MAPT is linked to Alzheimer disease.